Daniel Myran

Adjunct Scientist ICES uOttawa Mental Health & Addictions Research Program

Biography

Dr. Myran is a public health and family medicine physician and researcher. His program of research involves using health administrative data to examine the burden and societal impact of mental health conditions and substance use. His primary focus is examining the health impacts of changes in alcohol and drug policies and their influence on health inequities. As a secondary area of interest he uses big data to examine the health of physicians in Ontario.

CCFP, Family Medicine, University of Ottawa
FRCPC, Public Health and Preventive Medicine, University of Ottawa
MPH, Quantitative Methods, Harvard University
MD, Western University

Drug policy
Mental health and addictions
Public health
Epidemiology

Investigator, Bruyere Research Institute
Assistant Professor, Department of Family Medicine, University of Ottawa
Associate Scientist, Ottawa Hospital Research Institute

Awards & Recognition

13/03/2024

Tier 2 Canada Research Chair in Social Accountability

2024: Awarded to Dr. Daniel Myran. The research goal is to examine the health consequences of substance use including an in-depth examination of the health impact of alcohol and drug policy in Canada.

Awards & Recognition

25/03/2023

Early Career Researcher of the Year – Public Health and Epidemiology

2023: Awarded to Dr. Daniel Myran by the University of Ottawa Faculty of Medicine.

Awards & Recognition

15/06/2018

Gareth M. Green Award

2018: Awarded to Dr. Daniel Myran by the Harvard T. H. Chan School of Public Health.

See All

Journal Articles

Journal Article

05/02/2024

Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

Myran DT, Harrison LD, Pugliese M, Tanuseputro P, Gaudreault A, Fiedorowicz JG, Solmi M. EClinicalMedicine. 2024; Feb 5 [Epub ahead of print].

Journal Article

01/02/2024

Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

Myran DT, Gaudreault A, Pugliese M, Tanuseputro P, Saunders N. J Affect Disord. 2024; Feb 1 [Epub ahead of print].

Journal Article

14/12/2023

Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol

Harrison LD, Dumicho AY, Bader Eddeen A, Tanuseputro P, Kendall CE, Fiedorowicz JG, Rosic T, Fernando SM, McNaughton CD, Corace K, Kurdyak P, Beckerleg W, Webber C, Gardner W, Sood M, Myran DT.

Journal Article

10/12/2023

Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada

Anderson KK, Rodrigues R, Le B, Mamun M, Archie S, Edwards J, Elton-Marshall T, Gilliland J, Myran DT, Palaniyappan L, Perlman CM, Seabrook JA, Murray RM, Shariff SZ. Int J Drug Policy. 2023; Dec 10 [Epub ahead of print].

Journal Article

01/12/2023

Unintentional pediatric poisonings before and during the COVID-19 pandemic: a population-based study

Myran DT, Gaudreault A, McCarthy SDS, Pugliese M, Tanuseputro P, Finkelstein Y. Am J Emerg Med. 2023; Dec 1 [Epub ahead of print].

Journal Article

27/10/2023

The effect of non-medical cannabis retailer proximity on use of mental health services for psychotic disorders in Ontario, Canada

Wootten JC, Rodrigues R, Gilliland J, Carter B, Shariff SZ, Zhong S, Archie S, Edwards J, Elton-Marshall T, Myran DT, Palaniyappan L, Perlman CM, Seabrook JA, Murray RM, Anderson KK. Int J Soc Psychiatry. 2023; Oct 27 {Epub ahead of print].

Journal Article

27/09/2023

Transition to schizophrenia spectrum disorder following emergency department visits due to substance use with or without psychosis

Myran DT, Harrison LD, Pugliese M, Solmi M, Anderson KK, Fiedorowicz JG, Perlman CM, Webber C, Finkelstein Y, Tanuseputro P. JAMA Psych. 2023; Sep 27 [Epub ahead of print].

Journal Article

06/09/2023

Cannabis-involved traffic injury emergency department visits after cannabis legalization and commercialization

Myran DT, Gaudreault A, Pugliese M, Manuel D, Tanuseputro P. JAMA Netw Open. 2023; 6(9):e2331551. Epub 2023 Sep 6.

Journal Article

27/07/2023

Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis

Myran DT, Pugliese M, Roberts RL, Solmi M, Perlman CM, Fiedorowicz J, Tanuseputro P, Anderson KK. Mol Psychiatry. 2023; Jul 27 {Epub ahead of print].

Journal Article

23/05/2023

Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario

Myran DT, Roberts R, Pugliese M, Corsi D, Walker M, El-Chaâr D, Tanuseputro P, Simpson A. CMAJ. 2023; 195(20):E699-708. Epub 2023 May 23.

See All

News Coverage

News Release

05/02/2024

Get in touch with
Daniel Myran

"*" indicates required fields

Daniel Myran

Biography

Education

Research Focus

Other Affiliations

Awards & Recognition

Tier 2 Canada Research Chair in Social Accountability

Early Career Researcher of the Year – Public Health and Epidemiology

Gareth M. Green Award

Journal Articles

Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol

Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada

Unintentional pediatric poisonings before and during the COVID-19 pandemic: a population-based study

The effect of non-medical cannabis retailer proximity on use of mental health services for psychotic disorders in Ontario, Canada

Transition to schizophrenia spectrum disorder following emergency department visits due to substance use with or without psychosis

Cannabis-involved traffic injury emergency department visits after cannabis legalization and commercialization

Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis

Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario

News Coverage

Heavy cannabis use increases risk of developing an anxiety disorder, study suggests

Emergency department visits for substance use linked to higher risk of developing schizophrenia

Commercialization of cannabis linked to increased traffic injuries

Get in touch with
Daniel Myran

Daniel Myran

Biography

Education

Research Focus

Other Affiliations

Awards & Recognition

Tier 2 Canada Research Chair in Social Accountability

Early Career Researcher of the Year – Public Health and Epidemiology

Gareth M. Green Award

Journal Articles

Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol

Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada

Unintentional pediatric poisonings before and during the COVID-19 pandemic: a population-based study

The effect of non-medical cannabis retailer proximity on use of mental health services for psychotic disorders in Ontario, Canada

Transition to schizophrenia spectrum disorder following emergency department visits due to substance use with or without psychosis

Cannabis-involved traffic injury emergency department visits after cannabis legalization and commercialization

Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis

Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario

News Coverage

Heavy cannabis use increases risk of developing an anxiety disorder, study suggests

Emergency department visits for substance use linked to higher risk of developing schizophrenia

Commercialization of cannabis linked to increased traffic injuries

Get in touch with Daniel Myran

Get in touch with
Daniel Myran